Lyseng-Williamson, Katherine A.; Plosker, Greg L. - In: PharmacoEconomics 20 (2002) 13, pp. 919-942
Galantamine is one of several orally administered cholinesterase inhibitors that improve cognition in patients with mild to moderate Alzheimer's disease. Compared with placebo, galantamine 16 or 24 mg/day improved cognition and activities of daily living, delayed emergence of behavioural...
